Abingdon Health (LON:ABDX) Hits New 52-Week Low – Time to Sell?

Shares of Abingdon Health Plc (LON:ABDXGet Free Report) reached a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 6 ($0.08) and last traded at GBX 6.25 ($0.08), with a volume of 121997 shares. The stock had previously closed at GBX 6.50 ($0.09).

Abingdon Health Trading Down 3.8 %

The company has a 50 day simple moving average of GBX 7.22 and a 200 day simple moving average of GBX 7.82. The company has a market capitalization of £12.10 million, a PE ratio of -15.20 and a beta of 0.13. The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95.

Abingdon Health (LON:ABDXGet Free Report) last issued its quarterly earnings results on Monday, March 24th. The company reported GBX (0.53) (($0.01)) EPS for the quarter. Abingdon Health had a negative return on equity of 62.56% and a negative net margin of 20.72%.

About Abingdon Health

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.

Featured Articles

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.